Cargando…

Emerging Progress of RNA-Based Antitumor Therapeutics

RNA-based therapeutics (e.g., mRNAs, siRNAs, microRNAs, ASOs, and saRNAs) have considerable potential for tumor treatment. The development and optimization of RNA modifications and delivery systems enable the stable and efficient delivery of RNA cargos in vivo to elicit an antitumor response. Target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jiayan, Dong, Haiyang, Wu, Jian, Jin, Yongfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321292/ https://www.ncbi.nlm.nih.gov/pubmed/37416764 http://dx.doi.org/10.7150/ijbs.83732

Ejemplares similares

Trans-splicing facilitated by RNA pairing greatly expands sDscam isoform diversity but not homophilic binding specificity
por: Hou, Shouqing, et al.
Publicado: (2022)

Salmonella as an Innovative Therapeutic Antitumor Agent
por: Chang, Wen-Wei, et al.
Publicado: (2014)

Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy
por: Aishajiang, Reyida, et al.
Publicado: (2023)

Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis
por: Zhou, Dexi, et al.
Publicado: (2020)

Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals
por: Jiang, Siliang, et al.
Publicado: (2021)

Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma—Progress and Challenges
por: Nava, Victor E., et al.
Publicado: (2022)

A review of research progress of antitumor drugs based on tubulin targets
por: Cheng, Ziqi, et al.
Publicado: (2020)

Antitumoral RNA‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies
por: Taniguchi, Hiroaki, et al.
Publicado: (2022)

microRNA Therapeutics in Cancer — An Emerging Concept
por: Shah, Maitri Y., et al.
Publicado: (2016)

Innovative developments and emerging technologies in RNA therapeutics
por: Halloy, François, et al.
Publicado: (2022)

Progress of Iron-Based Nanozymes for Antitumor Therapy
por: Sutrisno, Linawati, et al.
Publicado: (2020)

Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
por: Sánchez, Manuel Lisardo, et al.
Publicado: (2023)

Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy
por: Liu, Xiaoli, et al.
Publicado: (2020)

Pyroptosis and Its Role in the Modulation of Cancer Progression and Antitumor Immunity
por: Qi, Sihan, et al.
Publicado: (2022)

Depletion of platelets enhances therapeutic antitumor effects generated by therapeutic DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2013)

Lipid metabolism in cancer progression and therapeutic strategies
por: Fu, Yan, et al.
Publicado: (2020)

MicroRNA: an Emerging Therapeutic Target and Intervention Tool
por: Liu, Zhen, et al.
Publicado: (2008)

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction
por: Cornelius, Victoria A., et al.
Publicado: (2022)

Complex RNA Secondary Structures Mediate Mutually Exclusive Splicing of Coleoptera Dscam1
por: Dong, Haiyang, et al.
Publicado: (2021)

Emerging roles of circRNA in formation and progression of cancer
por: Yin, Yuting, et al.
Publicado: (2019)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
por: Koch, Regina M., et al.
Publicado: (2021)

Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
por: Chuang, Chi-Mu, et al.
Publicado: (2009)

Current Progress of RNA Aptamer-Based Therapeutics
por: Zhou, Jiehua, et al.
Publicado: (2012)

Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression
por: Xu, Haili, et al.
Publicado: (2021)

The emerging roles of circular RNA-mediated autophagy in tumorigenesis and cancer progression
por: Yuan, Yuan, et al.
Publicado: (2022)

Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges
por: Li, Shu‐Jin, et al.
Publicado: (2021)

Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors
por: Qamar, Hina, et al.
Publicado: (2021)

Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy
por: Lo Iacono, Melania, et al.
Publicado: (2022)

Research Progress on Structural Modification of Effective Antitumor Active Ingredients in Licorice
por: Liu, Chi, et al.
Publicado: (2023)

Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
por: Wang, Hong, et al.
Publicado: (2021)

Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression
por: Serrano, Alfonso, et al.
Publicado: (2011)

Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses
por: Ciccone, Giuseppe, et al.
Publicado: (2023)

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
por: Wang, Haihua, et al.
Publicado: (2022)

Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers
por: Tortora, Fabiana, et al.
Publicado: (2023)

Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas
por: Choe, Jennifer, et al.
Publicado: (2018)

Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
por: Jin, Xiao, et al.
Publicado: (2020)

RNA-based therapeutics: an overview and prospectus
por: Zhu, Yiran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3edlklubu41noni5onofpobsk